Michael Andriole

(Mr. Michael Andriole)

Currently holds positions in Chimerix Inc and Endocyte Inc

Positions
Position Company Period
Chief Business Officer Chimerix Inc April 4, 2019 -
Chief Financial Officer Endocyte Inc Feb. 20, 2017 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-05-18 2022-05-17
US Chimerix Inc (CMRX)
PP Planned purchase
15,000 +7.6%
1.71
25,635 USD 		15,000 +7.6% 1.71 25,635 USD
2020-03-17 2020-03-16
US Chimerix Inc (CMRX)
PP Planned purchase
33,300 +28.6%
1.43
47,522 USD 		33,300 +28.6% 1.43 47,522 USD
2019-11-07 2019-11-06
US Chimerix Inc (CMRX)
B Purchase
100,000 +inf%
1.56
156,000 USD 		100,000 +inf% 1.56 156,000 USD